Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing
21/10/2025 12:55
Oct 21 (Reuters) - Oragenics Inc OGEN.A: ORAGENICS INC - ENTERS SETTLEMENT AGREEMENT WITH LADENBURG THALMANN - SEC FILING Source text: [ID:n0001493152-25-018725] Further company coverage: OGEN.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing